Abstract
OBJECTIVES
This retrospective study was conducted to evaluate the impact of saphenous vein (SV) harvesting with versus without perivascular tissue on the 5-year angiographic patency in coronary artery bypass grafting.
METHODS
Among the 944 patients who received coronary artery bypass grafting between 2010 and 2015, 579 patients who received off-pump coronary artery bypass grafting using 1 SV as a Y-composite graft based on the in situ left internal thoracic artery were enrolled. SV harvesting was performed using no-touch technique without perivascular tissue (the NoPVT group) in 342 patients and with perivascular tissue (the PVT group) in 237 patients. Follow-up duration was 84.0 months (interquartile range 66.5–105.4). Propensity score matching was performed, and long-term clinical outcomes and angiographic patency were compared.
RESULTS
The average number of distal anastomoses per patient was comparable between the groups, although more SV grafts were anastomosed to left anterior descending territory in the PVT group than in the NoPVT group. Overall survival and cumulative incidence of cardiac death were comparable between the groups, whereas cumulative incidence of target vessel revascularization (1.3% vs 4.3% at 5 year, P = 0.009) and that of major adverse cardiac events (7.3% vs 9.9% at 5 year, P = 0.035) were lower in the PVT group than in the NoPVT group. One-year and 5-year angiographic patency rates of the SV grafts were higher in the PVT group than in the NoPVT group [97.0% vs 91.7% (P = 0.004) and 96.3% vs 89.9% (P = 0.007), respectively].
CONCLUSIONS
SV grafts harvested using no-touch technique with perivascular tissue further improved the 5-year patency of SV composite grafts compared with those without perivascular tissue.
Keywords: Coronary artery bypass grafting, Saphenous vein, Angiography, Outcomes
The internal thoracic artery is considered the 1st graft of choice for coronary artery bypass grafting (CABG) because of its excellent long-term patency and survival benefit [1, 2].
Graphical Abstract
INTRODUCTION
The internal thoracic artery is considered the 1st graft of choice for coronary artery bypass grafting (CABG) because of its excellent long-term patency and survival benefit [1, 2]. Regarding the 2nd graft of choice, the use of multiple arterial grafting is still limited, and this strategy is performed in only 3.9–34.2% of CABG patients in North America and Europe [3]. In contrast, the saphenous vein (SV) graft, which was introduced more than 50 years ago [4], remains the most commonly used conduit despite the limitations of high failure rates in the short and long term [5–7].
Based on the no-touch (NT) SV harvesting technique, in which the SV is harvested and treated with minimal manipulation and manual intraluminal distension of the SV is avoided [8], a novel NT-SV grafting strategy that harvests the NT-SV with its surrounding perivascular tissue (PVT) was 1st introduced in 1996 [9], and previous studies have reported superior short- and long-term graft patency of novel NT-SV grafts compared with that of conventional SV grafts [10–12]. In addition to the benefits of preventing traumatic manipulation, avoiding manual luminal distension and preserving the vasa vasorum, previous studies have suggested that preserving the PVT might have additional benefits for the NT-SV [13, 14].
Therefore, the present retrospective observational single-centre study was conducted to investigate the impact of PVT preservation during SV harvest on the 5-year angiographic patency of SV grafts.
MATERIALS AND METHODS
Patient selection
The study protocol was reviewed by the Institutional Review Board and approved as a minimal risk retrospective study (approval number H-2201-116-1293), and individual consent was waived. Of 994 patients who received CABG between January 2010 and December 2015 at our institution, primary isolated off-pump CABG was performed in 880 patients. Among these patients, 579 patients who received off-pump CABG using the SV as a Y-composite graft based on in situ left internal thoracic artery (LITA) were enrolled in the present study. The SV was harvested using the NT technique with PVT (the PVT group) and without PVT (the NoPVT group) in 237 and 342 patients, respectively (Fig. 1).
Figure 1:
Flow diagram of patient enrolment. CABG: coronary artery bypass grafting; SV: saphenous vein; PVT: perivascular tissue; RGEA: right gastroepiploic artery; RITA: right internal thoracic artery.
Operative techniques and revascularization strategy
The operative procedures and surgical strategies of CABG have been illustrated in previous studies [15, 16]. During the study period, anaortic off-pump CABG using Y-composite grafting based on the in situ LITA was the preferred revascularization strategy for CABG at our institution to minimize cerebrovascular complications [17]. The SV has been used as the preferred 2nd conduit of choice to construct Y-composite grafts based on our studies showing non-inferiority of the SV compared to arterial conduits [16, 18]. The NT-SV was harvested without PVT until September 2013. Since October 2013, the NT-SV was harvested with a substantial margin of PVT on both sides of the SV and with thin layers of adherent connective tissues anteriorly and posteriorly (Fig. 2).
Figure 2:
No-touch saphenous vein graft harvest with perivascular tissue.
The NT-SV was harvested preferentially from a lower leg to alleviate the possible size mismatch with native coronary arteries or ITAs, although it resulted in numbness around the lower leg incision in most of the patients. Immediately after the harvest, the reversed SV was anastomosed to the posterior aspect of the mid-LITA in an end-to-side fashion to construct a Y-composite graft. After the construction of the Y-composite graft, the left anterior descending coronary artery territory was revascularized 1st. Then, the left circumflex coronary artery territory was revascularized, followed by right coronary artery territory. A sequential anastomotic technique was also used as needed.
Evaluation of clinical outcomes
Operative mortality was defined as any mortality within 30 days after surgery or during the same hospitalization. After discharge, all patients visited the outpatient clinic regularly at 3- to 6-month intervals. If the patients had not visited the outpatient clinic as scheduled, their survival and conditions were checked by telephone. For the patients in the loss of follow-ups, their survival data were obtained from the National Health Insurance Service and the Statistics Korea, a central organization for statistics under the Ministry of Strategy and Finance. The clinical follow-up was closed on 31 December 2021. Follow-up data were complete in 100% and 99.5% (576 out of 579 patients) for survival and the other clinical outcomes, respectively, with a median follow-up duration of 84.0 months [interquartile range (IQR) 66.5–105.4].
Cardiac death was defined as any death related to cardiac events, including sudden death during follow-up. Reintervention included both percutaneous coronary intervention and coronary reoperation. Reintervention was further divided into target vessel revascularization (TVR), which was defined as coronary interventions of target vessels that were bypassed during the index operation, and non-TVR, which was defined as coronary interventions for a new lesion outside the target vessels. Major adverse cardiac events included cardiac death, acute myocardial infarction and coronary reintervention.
Angiographic evaluation of graft patency
Early, 1-year and 5-year follow-up coronary angiograms were performed based on the patient’s consent, regardless of angina symptoms. Patients who died, refused angiographic evaluation or had renal function impairment but were not dependent on renal replacement therapy were excluded from angiographic follow-up. Early postoperative [1 day (IQR 1–1)] graft evaluation was performed in 99.1% (574 out of 579) of the study patients with conventional angiography. One-year [12.5 months (IQR 12.1–13.3)] graft evaluation was performed in 491 patients (84.8%) using conventional angiography and multidetector computed tomography (MDCT) in 274 and 217 patients, respectively. Five-year [60.5 months (IQR 59.9–62.1)] graft evaluation was performed in 386 patients (66.7%) with conventional angiography and MDCT in 85 and 301 patients, respectively (Supplementary Material, Table S1).
Statistical analysis
Statistical analysis was performed using IBM SPSS version 25.0 (IBM Corp., Armonk, NY, USA) and SAS version 9.4 (SAS Institute Inc., Cary, NC, USA). Continuous variables are presented as the mean ± standard deviation or median with interquartile range, and categorical variables are presented as the number and proportion. Propensity score-matched analysis was performed to adjust the differences in preoperative characteristics. Eighteen variables in baseline characteristics were selected for the propensity score-matched analysis including age, sex, smoking, body mass index >25.0 kg/m2, hypertension, diabetes mellitus, dyslipidaemia, history of stroke, chronic kidney disease, chronic obstructive pulmonary disease, atrial fibrillation, peripheral vascular disease, previous percutaneous coronary intervention, left ventricular ejection fraction <0.35, preoperative diagnosis, 3-vessel disease, left main disease and emergency operation. After calculating the propensity scores, 232 pairs were matched using a nearest neighbourhood within a calliper width of 0.1 in propensity scores and with a ratio of 1:1. The balance of covariates between the groups was evaluated with the standardized mean difference. A standardized mean difference of <0.100 was considered as a negligible difference between the groups.
In the unmatched population, the 2 groups were compared using the chi-square test or Fisher’s exact test for categorical variables and Student’s t-test or Wilcoxon rank sum test for continuous variables. In the matched population, McNemar tests were performed for categorical variables, and Wilcoxon signed rank sum tests or paired t tests were performed for continuous variables. Comparison of the graft patency rates between the 2 groups was performed using logistic regression with generalized estimating equations to account for the clustering of multiple measurements per subject.
For longitudinal data analyses, overall survival was estimated using the Kaplan–Meier method and compared with the log-rank test. Cardiac death, TVR, reintervention and major adverse cardiac events were analysed with cumulative incidence curves. Noncardiac death was considered a competing event for cardiac death, and all-cause death was considered a competing event for the other outcomes. Comparison of cumulative incidence curves between the 2 groups was performed using a subdistribution hazards model [19]. A P value of <0.050 was considered to indicate statistical significance.
RESULTS
Patient characteristics
The mean age was 67.0 ± 9.7 years, and 24.2% (140 out of 579) of the patients were female. There were no differences in demographic data or preoperative risk factors between the 2 groups, except for a higher proportion of patients with a history of percutaneous coronary intervention in the PVT group than in the NoPVT group (19.8% vs 13.5%, P = 0.040). After propensity score matching, the differences in patient characteristics between the groups significantly reduced (Table 1).
Table 1:
Preoperative characteristics and risk factors for the study patients
| All study patients |
Propensity-matched patients |
|||||||
|---|---|---|---|---|---|---|---|---|
| Variables | Group PVT (n = 237) | Group NoPVT (n = 342) | SMD | P | Group PVT (n = 232) | Group NoPVT (n = 232) | SMD | P |
| Age (years) | 67.5 ± 9.4 | 66.7 ± 9.9 | 0.073 | 0.588 | 67.4 ± 9.5 | 66.8 ± 10.4 | 0.050 | 0.865 |
| Sex (female), n (%) | 60 (25.3) | 80 (23.4) | 0.045 | 0.595 | 60 (25.9) | 57 (24.6) | 0.030 | 0.824 |
| EuroSCORE II | 1.2 (0.9–2.2) | 1.4 (0.9–2.5) | –0.044 | 0.176 | 1.2 (0.9–2.2) | 1.5 (0.9–2.5) | –0.038 | 0.292 |
| Risk factors, n (%) | ||||||||
| Smoking | 75 (31.6) | 133 (38.9) | –0.152 | 0.074 | 73 (31.5) | 84 (36.2) | –0.100 | 0.284 |
| Body mass index >25.0 kg/m2 | 86 (36.3) | 143 (41.8) | –0.114 | 0.181 | 85 (36.6) | 91 (39.2) | –0.054 | 0.624 |
| Hypertension | 169 (71.3) | 241 (70.5) | 0.019 | 0.827 | 166 (71.6) | 164 (70.7) | 0.019 | 0.918 |
| Diabetes mellitus | 113 (47.7) | 160 (46.8) | 0.018 | 0.832 | 110 (47.4) | 104 (44.8) | 0.052 | 0.643 |
| Dyslipidaemia | 85 (35.9) | 123 (36.0) | –0.002 | 0.980 | 84 (36.2) | 90 (38.8) | –0.053 | 0.634 |
| History of stroke | 31 (13.1) | 49 (14.3) | –0.036 | 0.669 | 31 (13.4) | 33 (14.2) | –0.025 | 0.896 |
| Chronic kidney disease | 59 (24.9) | 79 (22.2) | 0.063 | 0.455 | 57 (24.6) | 56 (24.1) | 0.010 | >0.999 |
| Chronic obstructive pulmonary disease | 11 (4.6) | 8 (2.3) | 0.126 | 0.126 | 8 (3.4) | 8 (3.4) | <0.001 | >0.999 |
| Atrial fibrillation | 5 (2.1) | 8 (2.3) | –0.016 | 0.855 | 5 (2.2) | 6 (2.6) | –0.028 | >0.999 |
| Peripheral vascular disease | 12 (5.1) | 16 (4.7) | 0.018 | 0.832 | 12 (5.2) | 12 (5.2) | <0.001 | >0.999 |
| Previous percutaneous coronary intervention | 47 (19.8) | 46 (13.5) | 0.172 | 0.040 | 44 (19.0) | 44 (19.0) | <0.001 | >0.999 |
| Left ventricular ejection fraction <0.35 | 27 (11.4) | 54 (15.8) | –0.129 | 0.134 | 26 (11.2) | 25 (10.8) | 0.014 | >0.999 |
| Preoperative diagnosis, n (%) | ||||||||
| Stable angina | 86 (36.3) | 112 (32.7) | 0.075 | 0.377 | 83 (35.8) | 83 (35.8) | <0.001 | >0.999 |
| Acute coronary syndrome | 151 (63.7) | 230 (67.3) | –0.075 | 0.377 | 149 (64.2) | 149 (64.2) | <0.001 | >0.999 |
| Three-vessel disease, n (%) | 188 (79.3) | 277 (81.0) | –0.042 | 0.619 | 185 (79.7) | 184 (79.3) | 0.011 | >0.999 |
| Left main disease, n (%) | 107 (45.1) | 132 (38.6) | 0.133 | 0.115 | 102 (44.0) | 102 (44.0) | <0.001 | >0.999 |
| Emergency operation, n (%) | 4 (1.7) | 6 (1.8) | –0.005 | >0.999 | 4 (1.7) | 4 (1.7) | <0.001 | >0.999 |
Continuous variables are presented as the average ± standard deviation for normally distributed variables, and median with interquartile range for non-normally distributed variables.
PVT: perivascular tissue; SMD: standardized mean difference.
Operative data
The number of distal anastomoses per patient ranged from 2 to 6, and was comparable between the groups. The number of distal anastomoses per LITA was smaller in the PVT group than in the NoPVT group, whereas that per SV was greater in the PVT group than in the NoPVT group. These findings regarding the numbers of distal anastomoses remained consistent after propensity score matching (Table 2).
Table 2:
Comparison of the number of distal anastomoses between the groups
| All study patients |
Propensity-matched patients |
|||||
|---|---|---|---|---|---|---|
| Variables | Group PVT (n = 237) | Group NoPVT (n = 342) | P | Group PVT (n = 232) | Group NoPVT (n = 232) | P |
| Number of distal anastomosis per patient | ||||||
| 2 | 14 (5.9%) | 23 (6.7%) | 0.692 | 14 (6.0%) | 17 (7.3%) | 0.577 |
| 3 | 80 (33.8%) | 113 (33.0%) | 0.858 | 78 (33.6%) | 75 (32.3%) | 0.767 |
| 4 | 100 (42.2%) | 159 (46.5%) | 0.307 | 98 (42.2%) | 104 (44.8%) | 0.574 |
| 5 | 40 (16.9%) | 44 (12.9%) | 0.178 | 39 (16.8%) | 33 (14.2%) | 0.442 |
| 6 | 3 (1.3%) | 3 (0.9%) | 0.693 | 3 (1.3%) | 3 (1.3%) | >0.999 |
| Number of distal anastomosis per LITA | ||||||
| 1 | 226 (95.4%) | 278 (81.3%) | <0.001 | 221 (95.3%) | 194 (83.6%) | <0.001 |
| 2 | 11 (4.6%) | 62 (18.1%) | <0.001 | 11 (4.7%) | 37 (15.9%) | <0.001 |
| 3 | 0 (0.0%) | 2 (0.6%) | 0.516 | 0 (0.0%) | 1 (0.4%) | >0.001 |
| Number of distal anastomosis per SV | ||||||
| 1 | 15 (6.3%) | 30 (8.8%) | 0.280 | 15 (6.5%) | 21 (9.1%) | 0.298 |
| 2 | 82 (34.6%) | 136 (39.8%) | 0.207 | 80 (34.5%) | 86 (37.1%) | 0.561 |
| 3 | 103 (43.5%) | 155 (45.3%) | 0.658 | 101 (43.5%) | 106 (45.7%) | 0.641 |
| 4 | 35 (14.8%) | 21 (6.1%) | <0.001 | 34 (14.7%) | 19 (8.2%) | 0.029 |
| 5 | 2 (0.8%) | 0 (0.0%) | 0.167 | 2 (0.9%) | 0 (0.0%) | 0.499 |
| Anastomosed to LAD territory | ||||||
| 0 | 80 (33.8%) | 173 (50.6%) | <0.001 | 80 (34.5%) | 114 (49.1%) | 0.001 |
| 1 | 152 (64.1%) | 169 (49.4%) | <0.001 | 148 (63.8%) | 118 (50.9%) | 0.005 |
| 2 | 5 (2.1%) | 0 (0.0%) | 0.011 | 4 (1.7%) | 0 (0.0%) | 0.123 |
| Anastomosed to LCx territory | ||||||
| 0 | 23 (9.7%) | 26 (7.6%) | 0.371 | 22 (9.5%) | 16 (6.9%) | 0.310 |
| 1 | 154 (65.0%) | 236 (69.0%) | 0.310 | 150 (64.7%) | 156 (67.2%) | 0.557 |
| 2 | 58 (24.5%) | 79 (23.1%) | 0.702 | 58 (25.0%) | 59 (25.4%) | 0.915 |
| 3 | 2 (0.8%) | 1 (0.3%) | 0.571 | 2 (0.9%) | 1 (0.4%) | >0.999 |
| Anastomosed to RCA territory | ||||||
| 0 | 59 (24.9%) | 90 (26.3%) | 0.700 | 57 (24.6%) | 66 (28.4%) | 0.344 |
| 1 | 156 (65.8%) | 219 (64.0%) | 0.658 | 154 (66.4%) | 140 (60.3%) | 0.177 |
| 2 | 22 (9.3%) | 33 (9.6%) | 0.882 | 21 (9.1%) | 26 (11.2%) | 0.442 |
Continuous variables are presented as median with interquartile range for non-normally distributed variables.
LAD: left anterior descending; LCx: left circumflex; LITA: left internal thoracic artery; PVT: perivascular tissue; RCA: right coronary artery; SV: saphenous vein.
Early and long-term clinical outcomes
Operative mortality was 0.9% (5 out of 579 patients) without an inter-group difference. There were no significant differences in the occurrence rates of postoperative complications between the 2 groups both in the entire population and in the matched population, except for the higher incidence of SV harvest site complications in the PVT group (Table 3).
Table 3:
Comparison of early clinical outcomes between the groups
| All study patients |
Propensity-matched patients |
|||||
|---|---|---|---|---|---|---|
| Variables | Group PVT (n = 237) | Group NoPVT (n = 342) | P | Group PVT (n = 232) | Group NoPVT (n = 232) | P |
| Operative mortality, n (%) | 3 (1.3) | 2 (0.6) | 0.404 | 3 (1.3) | 2 (0.9) | >0.999 |
| Postoperative complications, n (%) | ||||||
| Postoperative atrial fibrillation | 88 (37.1) | 113 (33.0) | 0.309 | 86 (37.1) | 76 (32.8) | 0.373 |
| Acute kidney injury | 14 (5.9) | 26 (7.6) | 0.429 | 14 (6.0) | 20 (8.6) | 0.327 |
| Respiratory complications | 14 (5.9) | 20 (5.8) | 0.976 | 14 (6.0) | 13 (5.6) | >0.999 |
| Delirium | 12 (5.1) | 11 (3.2) | 0.263 | 12 (5.2) | 5 (2.2) | 0.143 |
| Bleeding reoperation | 5 (2.1) | 10 (2.9) | 0.606 | 4 (1.7) | 8 (3.4) | 0.344 |
| Stroke | 1 (0.4) | 2 (0.6) | >0.999 | 1 (0.4) | 2 (0.9) | >0.999 |
| Mediastinitis | 1 (0.4) | 2 (0.6) | >0.999 | 1 (0.4) | 1 (0.4) | >0.999 |
| SV harvest site complications | 8 (3.4) | 2 (0.6) | 0.019 | 8 (3.4) | 2 (0.9) | 0.109 |
PVT: perivascular tissue; SV: saphenous vein.
In the entire population, 5-year overall survival rates (PVT vs NoPVT groups = 81.0% vs 81.0%, P = 0.223) and cumulative incidences of cardiac death (5.5% vs 4.4%, P = 0.936) were not significantly different between the 2 groups, whereas the 5-year cumulative incidence of TVR was lower in the PVT group than in the NoPVT group (1.3% vs 3.2%, P = 0.027) (Supplementary Material, Fig. S1). In the matched population, 5-year overall survival rates and cumulative incidences of cardiac death consistently demonstrated no significant differences between the groups. However, the cumulative incidence of TVR (1.3% vs 4.3% at 5 year, P = 0.009) and that of major adverse cardiac events (7.3% vs 9.9% at 5 year, P = 0.035) were significantly lower in the PVT group than in the NoPVT group. The cumulative incidence of reintervention was also lower in the PVT group with a marginal significance (2.2% vs 5.2% at 5 year, P = 0.057) (Fig. 3).
Figure 3:
Comparison of (A) overall survival, (B) cumulative incidence of cardiac death, (C) cumulative incidence of target vessel revascularization (TVR), (D) cumulative incidence of reintervention and (E) cumulative incidence of major adverse cardiac events (MACEs) between the groups in the propensity score-matched population. MACE: major adverse cardiac event; NoPVT: without PVT; PVT: perivascular tissue; TVR: target vessel revascularization.
Angiographic graft patency
Early, 1-year and 5-year postoperative overall graft patency rates in the PVT versus NoPVT groups were 99.2% vs 97.9%, 97.6% vs 93.3% and 96.5% vs 92.2% in the matched cohort, respectively. All the obstructions occurred in distal anastomosis or distal graft, and no obstruction occurred at the level of Y-graft. There were no significant differences in graft patency rates of LITA between the 2 groups [early, 1 year and 5 years = 99.6% vs 99.6% (P = 0.941), 99.0% vs 97.0% (P = 0.154) and 97.0% vs 97.2% (P = 0.959), respectively], whereas patency rates of SV were significantly higher in the PVT group than in the NoPVT group at early, 1-year and 5-year angiograms (99.0% vs 97.1%, 97.0% vs 91.7% and 96.3% vs 89.9%, respectively) (Table 4). When the graft patency rates of the SV were analysed based on the coronary artery territory, they were highest when anastomosed to the left anterior descending coronary artery territory and lowest when anastomosed to the right coronary artery territory in both groups and in all time periods before and after matching. The patency rates of the SV to the right coronary artery territory showed significant differences between the 2 groups at 1 and 5 years [94.7% (161 of 170 distal anastomoses) vs 83.4% (141 of 169 distal anastomoses), P = 0.003 and 93.3% (126 of 135 distal anastomoses) vs 82.6% (100 of 121 distal anastomoses), P = 0.013, respectively], whereas there were no significant differences in the patency rates of the SV to the left anterior descending coronary artery territory in all time periods (Table 5).
Table 4:
Comparison of early, 1-year and 5-year angiographic patency rates of all anastomoses between the groups
| All study patients |
Propensity-matched patients |
|||||
|---|---|---|---|---|---|---|
| Variables | Group PVT (n = 237) | Group NoPVT (n = 342) | P | Group PVT (n = 232) | Group NoPVT (n = 232) | P |
| Early angiography | (n = 235) | (n = 339) | (n = 230) | (n = 229) | ||
| Overall | 99.1% (811/818) | 97.9% (1221/1247) | 0.021 | 99.2% (854/861) | 97.9% (828/846) | 0.029 |
| LITA | 99.6% (245/246) | 99.3% (402/405) | 0.602 | 99.6% (240/241) | 99.6% (267/268) | 0.941 |
| SV | 99.1% (628/634) | 97.3% (819/842) | 0.018 | 99.0% (614/620) | 97.1% (561/578) | 0.017 |
| One-year angiography | (n = 200) | (n = 291) | (n = 197) | (n = 203) | ||
| Overall | 97.6% (735/753) | 94.0% (1009/1073) | 0.003 | 97.6% (723/741) | 93.3% (701/751) | 0.002 |
| LITA | 99.0% (208/210) | 97.7% (335/343) | 0.253 | 99.0% (205/207) | 97.0% (227/234) | 0.154 |
| SV | 97.1% (527/543) | 92.3% (675/731) | 0.006 | 97.0% (518/534) | 91.7% (475/518) | 0.004 |
| Five-year angiography | (n = 160) | (n = 226) | (n = 159) | (n = 152) | ||
| Overall | 96.6% (588/609) | 93.3% (774/830) | 0.022 | 96.5% (581/602) | 92.2% (519/563) | 0.010 |
| LITA | 97.1% (165/170) | 97.0% (260/268) | 0.962 | 97.0% (164/169) | 97.2% (171/176) | 0.959 |
| SV | 96.4% (423/439) | 91.5% (514/562) | 0.020 | 96.3% (417/433) | 89.9% (348/387) | 0.007 |
LITA, left internal thoracic artery; PVT, perivascular tissue; SV, saphenous vein.
Table 5:
Comparison of early, 1-year and 5-year angiographic patency rates of the anastomoses with saphenous vein grafts between the groups
| All study patients |
Propensity-matched patients |
|||||
|---|---|---|---|---|---|---|
| Variables | Group PVT (n = 237) | Group NoPVT (n = 342) | P | Group PVT (n = 232) | Group NoPVT (n = 232) | P |
| Early angiography | (n = 235) | (n = 339) | (n = 230) | (n = 229) | ||
| Overall SV anastomoses | 99.1% (628/634) | 97.3% (819/842) | 0.018 | 99.0% (614/620) | 97.1% (561/578) | 0.017 |
| Anastomosed to LAD territory | 100.0% (161/161) | 100.0% (167/167) | – | 100.0% (155/155) | 100.0% (116/116) | – |
| Anastomosed to LCx territory | 99.6% (272/273) | 98.2% (385/392) | 0.136 | 99.6% (268/269) | 98.2% (267/272) | 0.142 |
| Anastomosed to RCA territory | 97.5% (195/200) | 94.3% (267/283) | 0.105 | 97.4% (191/196) | 93.7% (178/190) | 0.086 |
| One-year angiography | (n = 200) | (n = 291) | (n = 197) | (n = 203) | ||
| Overall SV anastomoses | 97.1% (527/543) | 92.3% (675/731) | 0.006 | 97.0% (518/534) | 91.7% (475/518) | 0.004 |
| Anastomosed to LAD territory | 98.5% (132/134) | 97.9% (140/143) | 0.708 | 98.5% (129/131) | 98.1% (103/105) | 0.825 |
| Anastomosed to LCx territory | 97.9% (231/236) | 94.8% (328/346) | 0.091 | 97.9% (228/233) | 94.7% (231/244) | 0.104 |
| Anastomosed to RCA territory | 94.8% (164/173) | 85.5% (207/242) | 0.006 | 94.7% (161/170) | 83.4% (141/169) | 0.003 |
| Five-year angiography | (n = 160) | (n = 226) | (n = 159) | (n = 152) | ||
| Overall SV anastomoses | 96.4% (423/439) | 91.5% (514/562) | 0.020 | 96.3% (417/433) | 89.9% (348/387) | 0.007 |
| Anastomosed to LAD territory | 99.1% (108/109) | 96.5% (109/113) | 0.222 | 99.1% (105/106) | 96.4% (80/83) | 0.239 |
| Anastomosed to LCx territory | 96.9% (187/193) | 93.0% (251/270) | 0.103 | 96.9% (186/192) | 91.8% (168/183) | 0.063 |
| Anastomosed to RCA territory | 93.4% (128/137) | 86.0% (154/179) | 0.044 | 93.3% (126/135) | 82.6% (100/121) | 0.013 |
LAD: left anterior descending; LCX: left circumflex; PVT: perivascular tissue; RCA: right coronary artery; SV: saphenous vein.
DISCUSSION
The present study demonstrated that preservation of PVT in NT-SV harvesting might be beneficial in terms of 5-year angiographic patency and cumulative incidence of TVR after CABG.
The concept of preserving the wall characteristics of SV grafts by the NT technique, which was inspired by the poor patency rates of SV grafts after CABG, was introduced in the early period of CABG, but it was not popularized [8]. A novel NT-SV grafting strategy was then introduced in 1996 [9]. Following the harvest methods of NT-SV as originally described, the novel strategy included preservation of the surrounding PVT. Although recent guidelines recommend NT-SV as Class IIa when an open technique is used [20], data regarding the benefits of NT-SV with PVT in CABG are limited because most studies have been reported from Souza and his colleagues, who introduced this technique [10–12, 21, 22].
In addition to the benefit of the NT technique that prevents the SV wall structures, particularly endothelial integrity, from mechanical damage during surgery, preserving the PVT in the novel NT technique has several theoretical advantages. These included (i) saving the vasa vasorum that prevents the SV from transmural ischaemic damage and (ii) buffering against pulsatile stress of the arterial flow that reduces neointimal and medial thickening [23–26]. With this theoretical background, a previous randomized controlled trial enrolled 52 patients in each NT-SV and control group. That study showed that aortocoronary NT-SV with PVT resulted in favourable patency rates of 95.4%, 90% and 83% at 1.5, 8.5 and 16 years after CABG, respectively, although 16-year patency was evaluated in only 27 patients with 75 distal anastomoses [10, 11, 21]. Another randomized trial that enrolled 250 patients from multiple institutions demonstrated that the composite rate of severe stenosis or occlusion at 12 months after CABG was 7.8% (8 of 102 grafts) in the NT-SV group [27].
In the present study, the NT-SV grafts were all used as composite grafts based on in situ LITA. Study results showed that 1-year and 5-year patency of the NT-SV grafts without PVT were 92.3% and 91.5%, respectively, which might be lower than the former randomized controlled trial but comparable to the latter randomized controlled trial. The patency rates of the NT-SV in the PVT group were significantly higher than those in the NoPVT group and were comparable with those in previous studies using NT-SV with PVT.
In addition to the theoretical advantages described above, there has been growing evidence regarding the impact of the PVT on the NT-SV. Previous studies have suggested that adipose tissue in the PVT interacts with vascular smooth muscle cells and modulates vascular tone as well as externally supports vascular structures [28, 29]. Another study revealed that it is a major source of nitric oxide, which plays crucial roles in suppressing atherosclerosis [14]. In that study, the authors analysed residual SVs obtained during CABG and demonstrated that the PVT expressed high levels of enzymes related to nitric oxide synthesis, such as argininosuccinate synthase 1 and endothelial nitric oxide synthase.
The present study confirmed that the PVT of the NT-SV is beneficial for patency of the NT-SV grafts up to 5 years after surgery. These improved patencies might result in favourable clinical outcomes in the PVT group, although those outcomes were not significantly different from those of the NoPVT group, except for the cumulative incidence of TVR.
Study limitations
There are several limitations to the present study that must be recognized. First, this study was a single institutional study and was not performed in a prospective randomized manner, although all consecutive patients who met the inclusion criteria were enrolled and propensity score matching was performed. Second, 1-year and 5-year graft evaluations were not performed in all the study patients, and graft patency rates might be overestimated. Third, there was a discrepancy in the modality, conventional angiogram versus MDCT, to evaluate the graft patency. Although the diagnostic efficacy of MDCT has been well demonstrated as excellent [30], this discrepancy could affect the results. Fourth, patients were recruited to this study at different time points with no overlap. Although propensity score matching was performed to overcome retrospective nature of the present study, other changes to surgical practice may have influenced the study results. Fifth, the effect of early technical failure to the long-term patency should also be considered in the interpretation of the results because the difference in graft patency existed at early angiographic evaluation.
CONCLUSIONS
Preserving the PVT during NT-SV harvest might improve graft patency rates of the SV up to 5 years after CABG.
Supplementary Material
Glossary
ABBREVIATIONS
- CABG
Coronary artery bypass grafting
- IQR
Interquartile range
- LITA
Left internal thoracic artery
- MDCT
Multidetector computed tomography
- NoPVT
Without perivascular tissue
- NT
No-touch
- PVT
Perivascular tissue
- SV
Saphenous vein
- TVR
Target vessel revascularization
Contributor Information
Suk Ho Sohn, Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Yoonjin Kang, Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Ji Seong Kim, Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Jae Woong Choi, Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
Ho Young Hwang, Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
SUPPLEMENTARY MATERIAL
Supplementary material is available at ICVTS online.
FUNDING
None declared.
Conflict of interest: none declared.
DATA AVAILABILITY
The data underlying this article will be shared on reasonable request to the corresponding author.
Author contributions
Suk Ho Sohn: Conceptualization; Data curation; Investigation; Methodology; Writing—original draft. Yoonjin Kang: Data curation. Ji Seong Kim: Data curation. Jae Woong Choi: Data curation. Ho Young Hwang: Conceptualization; Data curation; Investigation; Supervision; Validation; Writing—review and editing.
Reviewer information
Interactive CardioVascular and Thoracic Surgery thanks Antonio Miceli, Stuart William Grant, Luis C. Maroto, Pedro Correia, Monica Contino and the other anonymous reviewers for their contribution to the peer review process of this article.
Presented at the AATS 103rd Annual Meeting in Los Angeles, May 7th 2023, as a poster.
REFERENCES
- 1. Kitamura S. Physiological and metabolic effects of grafts in coronary artery bypass surgery. Circ J 2011;75:766–72. [DOI] [PubMed] [Google Scholar]
- 2. Cameron A, Davis KB, Green G, Schaff HV.. Coronary bypass surgery with internal-thoracic-artery grafts—effects on survival over a 15-year period. N Engl J Med 1996;334:216–9. [DOI] [PubMed] [Google Scholar]
- 3. Gaudino M, Chikwe J, Falk V, Lawton JS, Puskas JD, Taggart DP.. Transatlantic editorial: the use of multiple arterial grafts for coronary revascularization in Europe and North America. J Thorac Cardiovasc Surg 2020;159:2254–9. [DOI] [PubMed] [Google Scholar]
- 4. Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. Ann Thorac Surg 1968;5:334–9. [DOI] [PubMed] [Google Scholar]
- 5. Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG. et al. ; VA Cooperative Study Group #207/297/364. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol 2004;44:2149–56. [DOI] [PubMed] [Google Scholar]
- 6. Lopes RD, Hafley GE, Allen KB, Ferguson TB, Peterson ED, Harrington RA. et al. Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med 2009;361:235–44. [DOI] [PubMed] [Google Scholar]
- 7. Magee MJ, Alexander JH, Hafley G, Ferguson TB, Gibson CM, Harrington RA. et al. ; PREVENT IV Investigators. Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV. Ann Thorac Surg 2008;85:494–9. [DOI] [PubMed] [Google Scholar]
- 8. Dries D, Mohammad SF, Woodward SC, Nelson RM.. The influence of harvesting technique on endothelial preservation in saphenous veins. J Surg Res 1992;52:219–25. [DOI] [PubMed] [Google Scholar]
- 9. Souza D. A new no-touch preparation technique. Technical notes. Scand J Thorac Cardiovasc Surg 1996;30:41–4. [DOI] [PubMed] [Google Scholar]
- 10. Souza DSR, Johansson B, Bojö L, Karlsson R, Geijer H, Filbey D. et al. Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: results of a randomized longitudinal trial. J Thorac Cardiovasc Surg 2006;132:373–8. [DOI] [PubMed] [Google Scholar]
- 11. Samano N, Geijer H, Liden M, Fremes S, Bodin L, Souza D.. The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: a randomized trial. J Thorac Cardiovasc Surg 2015;150:880–8. [DOI] [PubMed] [Google Scholar]
- 12. Verma S, Lovren F, Pan Y, Yanagawa B, Deb S, Karkhanis R. et al. Pedicled no-touch saphenous vein graft harvest limits vascular smooth muscle cell activation: the PATENT saphenous vein graft study. Eur J Cardiothorac Surg 2014;45:717–25. [DOI] [PubMed] [Google Scholar]
- 13. Ford CA, Mong K, Tabrizchi R.. Influence of tangential stress on mechanical responses to vasoactive agents in human saphenous vein with and without perivascular adipose tissue. Can J Cardiol 2006;22:1209–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Saito T, Kurazumi H, Suzuki R, Matsunaga K, Tsubone S, Lv B. et al. Perivascular adipose tissue is a major source of nitric oxide in saphenous vein grafts harvested via the no-touch technique. J Am Heart Assoc 2022;11:e020637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Kim YH, Oh HC, Choi JW, Hwang HY, Kim K-B.. No-touch saphenous vein harvesting may improve further the patency of saphenous vein composite grafts: early outcomes and 1-year angiographic results. Ann Thorac Surg 2017;103:1489–97. [DOI] [PubMed] [Google Scholar]
- 16. Hwang HY, Lee Y, Sohn SH, Choi JW, Kim K-B.. Equivalent 10-year angiographic and long-term clinical outcomes with saphenous vein composite grafts and arterial composite grafts. J Thorac Cardiovasc Surg 2021;162:1535–43.e4. [DOI] [PubMed] [Google Scholar]
- 17. Kim K-B, Kang CH, Chang W-I, Lim C, Kim JH, Ham BM. et al. Off-pump coronary artery bypass with complete avoidance of aortic manipulation. Ann Thorac Surg 2002;74:S1377–82. [DOI] [PubMed] [Google Scholar]
- 18. Hwang HY, Kim KB.. Saphenous vein as a composite graft from the internal thoracic artery. Ann Cardiothorac Surg 2018;7:686–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Austin PC, Fine JP.. Propensity-score matching with competing risks in survival analysis. Stat Med 2019;38:751–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U. et al. ; ESC Scientific Document Group. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 2019;40:87–165.30165437 [Google Scholar]
- 21. Souza DSR, Dashwood MR, Tsui JCS, Filbey D, Bodin L, Johansson B. et al. Improved patency in vein grafts harvested with surrounding tissue: results of a randomized study using three harvesting techniques. Ann Thorac Surg 2002;73:1189–95. [DOI] [PubMed] [Google Scholar]
- 22. Johansson BL, Souza DSR, Bodin L, Filbey D, Loesch A, Geijer H. et al. Slower progression of atherosclerosis in vein grafts harvested with ‘no touch’ technique compared with conventional harvesting technique in coronary artery bypass grafting: an angiographic and intravascular ultrasound study. Eur J Cardiothorac Surg 2010;38:414–9. [DOI] [PubMed] [Google Scholar]
- 23. Dreifaldt M, Souza DSR, Loesch A, Muddle JR, Karlsson MG, Filbey D. et al. The “no-touch” harvesting technique for vein grafts in coronary artery bypass surgery preserves an intact vasa vasorum. J Thorac Cardiovasc Surg 2011;141:145–50. [DOI] [PubMed] [Google Scholar]
- 24. Dreifaldt M, Souza D, Bodin L, Shi-Wen X, Dooley A, Muddle J. et al. The vasa vasorum and associated endothelial nitric oxide synthase is more important for saphenous vein than arterial bypass grafts. Angiology 2013;64:293–9. [DOI] [PubMed] [Google Scholar]
- 25. Ahmed SR, Johansson BL, Karlsson MG, Souza DS, Dashwood MR, Loesch A.. Human saphenous vein and coronary bypass surgery: ultrastructural aspects of conventional and “no-touch” vein graft preparations. Histol Histopathol 2004;19:421–33. [DOI] [PubMed] [Google Scholar]
- 26. Dashwood MR, Savage K, Tsui JCS, Dooley A, Shaw SG, Fernández Alfonso MS. et al. Retaining perivascular tissue of human saphenous vein grafts protects against surgical and distension-induced damage and preserves endothelial nitric oxide synthase and nitric oxide synthase activity. J Thorac Cardiovasc Surg 2009;138:334–40. [DOI] [PubMed] [Google Scholar]
- 27. Deb S, Singh SK, de Souza D, Chu MWA, Whitlock R, Meyer SR. et al. ; SUPERIOR SVG Study Investigators. SUPERIOR SVG: no touch saphenous harvesting to improve patency following coronary bypass grafting (a multi-Centre randomized control trial, NCT01047449). J Cardiothorac Surg 2019;14:85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Chang L, Garcia-Barrio MT, Chen YE.. Perivascular adipose tissue regulates vascular function by targeting vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2020;40:1094–109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Szasz T, Webb RC.. Perivascular adipose tissue: more than just structural support. Clin Sci (Lond) 2012;122:1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Jones CM, Athanasiou T, Dunne N, Kirby J, Aziz O, Haq A. et al. Multi-detector computed tomography in coronary artery bypass graft assessment: a meta-analysis. Ann Thorac Surg 2007;83:341–8. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data underlying this article will be shared on reasonable request to the corresponding author.